value-based care

Research in Review

Imaging Tests for Thyroid Cancer Do Not Improve Survival

07/29/2016

JCP Editors

Imaging tests after primary treatment for thyroid cancer may not lead to improved survival, according to a study published in BMJ. While incidences of thyroid cancer have continued to grow in recent years, the...

...

07/29/2016

Journal of Clinical Pathways

Research in Review

ESMO Magnitude of Clinical Benefit Scale Aids Cancer Decision-Making

07/14/2016

JCP Editors

A study out of the Medical University of Vienna, Austria, one of Europe’s largest cancer centers, asserts that the European Society for Medical Oncology (ESMO) Magnitude of Clinical Benefit Scale (MCBS) is a reliable...

A...

07/14/2016

Journal of Clinical Pathways

Interview

The Potentials and Barriers of Precision Medicine in Oncology

06/20/2016

In the mid-1980s, cancer researchers shifted their focus from determining the location of a cancer to identifying the genetic mutations that create it.1 This shift gave birth to a new field of study known as...

In the...

06/20/2016

Journal of Clinical Pathways

Conference Coverage

Perceptions of ICER Reports and Health Technology Assessments in the United States

06/20/2016

JCP Editors

Michael Barry, MD, PhD, clinical director at the National Centre for Pharmaceoeconomics in Dublin, Ireland, initiated the session, “Payers’ use of Independent Reports in Decision Making—Will There Be an ICER Effect,”...

...

06/20/2016

Journal of Clinical Pathways

How Value Frameworks Are Changing US Health Care

06/20/2016

JCP Editors

In “What’s Next for Value-Frameworks in the U.S.?” a key session at ISPOR 2016, Lowell E Schnipper, MD, chair of the American Society of Clinical Oncology (ASCO), began by discussing why ASCO made the decision to...

In...

06/20/2016

Journal of Clinical Pathways

Conference Coverage

2016 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Annual Meeting

06/20/2016

JCP Editors

Founded in 1995, the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is one of the leading organizations promoting the research of health economics and value-based care. Currently, ISPOR is...

...

06/20/2016

Journal of Clinical Pathways

Research in Review

Formula for Optimal Radiosurgery Dose Developed to Guide Brain Metastasis Treatment

06/15/2016

JCP Editors

Researchers from the department of radiation oncology at the VU University Medical Center in Amsterdam, the Netherlands, have proposed a novel formula for the optimization of radiosurgery dose for any given lesion...

...

06/15/2016

Journal of Clinical Pathways

Quality and Value: Measuring and Utilizing Both in Your Practice

06/07/2016

JCP Editors

Anne C Chiang, MD, PhD, Yale School of Medicine (New Haven, CT), spoke first at the “Quality and Value: Measuring and Utilizing Both in Your Practice” session at the 2016 American Society of Clinical Oncology Annual...

Anne C...

06/07/2016

Journal of Clinical Pathways

MACRA Town Hall: Effects on Your Medicare Reimbursement

06/06/2016

JCP Editors

At the “MACRA Town Hall: Effects on your Medicare Reimbursement,” session, Blase Polite, MD, MPP, University of Chicago, Illinois described MACRA using three key adjectives: personal, immediate, and certain. First,...

At the...

06/06/2016

Journal of Clinical Pathways

From the Field

Mock Clinical Pathways: A Method for Exploring the Oncology Clinical Pathway Development Process

05/06/2016

Bing-E Xu , PhD;

Bruce A. Feinberg , DO;

Monica Lingam , MS;

Abstract: Clinical pathways are a critical structural element in the effort to reduce variation in health care as well as to make costs and outcomes more predictable, measurable, and accountable. A mock clinical...

...

05/06/2016

Journal of Clinical Pathways